Pardo Ryan has filed a Form 144 indicating the sale of 2,216,585 shares of LifeStance Health Group, Inc. This transaction, valued at approximately $31.9 million, is significant as it reflects ongoing activity in the health services sector.

The filing reveals that the shares were sold on November 10, 2026, and were acquired through private placements over several dates, including April 1, 2024, and May 14, 2023. The shares sold are part of a larger holding that includes a total of 380,190,724 units outstanding for LifeStance Health Group.

LifeStance Health Group, based in Scottsdale, Arizona, operates within the health services industry, focusing on providing mental health care. The company has seen various transactions in its stock, indicating a dynamic market environment.

The filing specifies that the shares were sold by Kimberly Pardo, who is identified as an investor in the company. The broker facilitating this transaction is Merrill Lynch, Pierce, Fenner & Smith.

As the health services sector continues to evolve, this filing underscores the active participation of stakeholders like Pardo Ryan in managing their investments. The impact of such transactions can ripple through the industry, influencing investor sentiment and market dynamics.

Details were not available in the SEC filing regarding what happens next for Pardo Ryan or LifeStance Health Group following this sale.